Sale!

HBA2 Gene Thalassemia Alpha Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The HBA2 gene thalassemia alpha genetic test is a specific diagnostic tool designed to detect mutations in the HBA2 gene, which is one of the genes responsible for the production of the alpha globin component of hemoglobin. Mutations or deletions in this gene can lead to alpha thalassemia, a blood disorder that reduces the production of normal hemoglobin, the protein in red blood cells that carries oxygen to cells throughout the body. This condition can range from mild to severe, with the most severe form being fatal before or shortly after birth.

DNA Labs UAE offers this crucial genetic test for individuals who may be carriers or at risk of having children with alpha thalassemia. The test, priced at 4400 AED, involves analyzing the patient’s DNA to look for specific mutations in the HBA2 gene. It is particularly recommended for those with a family history of thalassemia or individuals of ethnic backgrounds with a higher prevalence of the disease, such as people of Mediterranean, Middle Eastern, South Asian, and African ancestries.

By identifying carriers of the HBA2 gene mutations, the test plays a vital role in genetic counseling, family planning, and in some cases, guiding treatment decisions for those affected by the condition. It provides valuable information that can help prevent the transmission of the disease to future generations and prepare for the medical management of affected individuals.

Description

HBA2 Gene Thalassemia Alpha Genetic Test

Test Name: HBA2 Gene Thalassemia Alpha Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Hematology

Doctor: Hematologist

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for HBA2 Gene Thalassemia, alpha NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with HBA2 Gene Thalassemia, alpha NGS Genetic DNA Test gene HBA2

Test Details: The HBA2 gene is responsible for producing the alpha-globin protein chains, which are essential components of hemoglobin. Thalassemia is a group of inherited blood disorders characterized by abnormal production of hemoglobin, leading to a decrease in red blood cell production and subsequent anemia. Alpha thalassemia is caused by mutations in the HBA2 gene, resulting in reduced or absent production of alpha-globin chains. These mutations can be detected through genetic testing, specifically Next-Generation Sequencing (NGS) technology. NGS genetic testing involves sequencing the DNA of an individual to identify specific genetic variations or mutations. In the case of HBA2 gene thalassemia, NGS can identify the specific mutations in the HBA2 gene that are responsible for the condition. This information can help with diagnosis, genetic counseling, and family planning. NGS genetic testing for HBA2 gene thalassemia is a useful tool in identifying individuals at risk for the condition and guiding appropriate medical management. It can also be used for carrier testing in individuals with a family history of thalassemia or for prenatal testing to determine if a fetus carries the mutation. Overall, NGS genetic testing for HBA2 gene thalassemia plays a crucial role in the identification and management of this inherited blood disorder.

Test Name	HBA2 Gene Thalassemia alpha Genetic Test
Components
Price	4400.0 AED
Sample Condition	Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery	3 to 4 Weeks
Method	NGS Technology
Test type	Hematology
Doctor	Hematologist
Test Department:	Genetics
Pre Test Information	Clinical History of Patient who is going for HBA2 Gene Thalassemia, alpha NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with HBA2 Gene Thalassemia, alpha NGS Genetic DNA Test gene HBA2
Test Details	The HBA2 gene is responsible for producing the alpha-globin protein chains, which are essential components of hemoglobin. Thalassemia is a group of inherited blood disorders characterized by abnormal production of hemoglobin, leading to a decrease in red blood cell production and subsequent anemia. Alpha thalassemia is caused by mutations in the HBA2 gene, resulting in reduced or absent production of alpha-globin chains. These mutations can be detected through genetic testing, specifically Next-Generation Sequencing (NGS) technology. NGS genetic testing involves sequencing the DNA of an individual to identify specific genetic variations or mutations. In the case of HBA2 gene thalassemia, NGS can identify the specific mutations in the HBA2 gene that are responsible for the condition. This information can help with diagnosis, genetic counseling, and family planning. NGS genetic testing for HBA2 gene thalassemia is a useful tool in identifying individuals at risk for the condition and guiding appropriate medical management. It can also be used for carrier testing in individuals with a family history of thalassemia or for prenatal testing to determine if a fetus carries the mutation. Overall, NGS genetic testing for HBA2 gene thalassemia plays a crucial role in the identification and management of this inherited blood disorder.